XML 12 R2.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Earnings - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Income Statement [Abstract]        
Net sales $ 523,826 $ 752,005 $ 1,964,401 $ 2,163,660
Costs and expenses:        
Cost of goods sold 395,511 562,516 1,447,942 1,621,531
Selling, general and administrative expenses 57,361 52,980 177,035 159,764
Research and development costs 34,522 40,661 106,029 123,359
Impairment of assets sold (Note 10)     37,902  
Restructuring charges (Note 16) 19,040   19,040  
Gain on cross-currency interest rate swaps, net (Note 8) (30,481)   (30,481)  
Interest expense 8,737 10,798 26,502 34,156
Interest income (377) (348) (1,340) (1,013)
Other (income) expense, net (Note 18) (5,503) (6,916) (31,991) (18,134)
Total costs and expenses 478,810 659,691 1,750,638 1,919,663
Earnings before income taxes 45,016 92,314 213,763 243,997
Income tax expense 6,551 26,207 30,607 51,191
Net earnings $ 38,465 $ 66,107 $ 183,156 $ 192,806
Earnings per share (Note 4):        
Basic earnings per share $ 0.62 $ 1.07 $ 2.95 $ 3.11
Diluted earnings per share $ 0.61 $ 1.02 $ 2.85 $ 2.99
Weighted Average Common Shares Outstanding (Note 4):        
Basic 62,309 61,941 62,188 61,977
Diluted 63,427 64,633 64,273 64,437